Hutchens & Kramer Investment Management Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Hutchens & Kramer Investment Management Group's LLY Position: Q2 2026 in Review
Hutchens & Kramer Investment Management Group increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $1.13M and bringing the position to 5,658 shares worth $6.79M. The position accounts for 1.82% of the portfolio, ranked #14.
Hutchens & Kramer Investment Management Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $39M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Hutchens & Kramer Investment Management Group held 5,658 shares of Eli Lilly worth $6.79M as of Q2 2026.
- Hutchens & Kramer Investment Management Group bought 1,110 Eli Lilly shares in Q2 2026, an estimated $1.13M.
- Eli Lilly made up 1.82% of Hutchens & Kramer Investment Management Group's portfolio in Q2 2026, its #14 holding.
- Hutchens & Kramer Investment Management Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Hutchens & Kramer Investment Management Group's Eli Lilly position peaked at $39M in Q2 2024.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2026, filed 9 Jul 2026.